Peripheral Blood Lymphocyte Therapy (EBV-specific cytotoxic T cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peripheral Blood Lymphocyte Therapy (EBV-specific cytotoxic T cells), covering 2012-06-06 to 2012-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation [Phase 2]